Page last updated: 2024-11-04

tetracaine and Retinopathy of Prematurity

tetracaine has been researched along with Retinopathy of Prematurity in 2 studies

Tetracaine: A potent local anesthetic of the ester type used for surface and spinal anesthesia.
tetracaine : A benzoate ester in which 4-N-butylbenzoic acid and 2-(dimethylamino)ethanol have combined to form the ester bond; a local ester anaesthetic (ester caine) used for surface and spinal anaesthesia.

Retinopathy of Prematurity: A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmed, M1
Forcina, B1
Bonsall, D1
Castellanos, MA1
Schwartz, S1
Leal, R1
Chan, RV1
Quiroz-Mercado, H1

Other Studies

2 other studies available for tetracaine and Retinopathy of Prematurity

ArticleYear
Quantifying and qualifying the useĀ of topical anesthetics in retinopathy of prematurity examinations.
    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2016, Volume: 20, Issue:2

    Topics: Administration, Topical; Anesthetics, Local; Gestational Age; Guidelines as Topic; Health Care Surve

2016
Pain assessment in premature infants treated with intravitreal antiangiogenic therapy for retinopathy of prematurity under topical anesthesia.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2013, Volume: 251, Issue:2

    Topics: Anesthesia, Local; Anesthetics, Local; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; B

2013